◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › I › IDXX

IDEXX Laboratories Inc (IDXX) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-16

IDEXX Laboratories Inc (IDXX) operates in the Health Care Equipment industry and is headquartered in Westbrook, United States with about 11,000 employees. Its market capitalization is roughly $40 billion. In the fiscal year ended 2025-12-31, IDXX reported $4.3B in revenue and $1.1B in net income.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.

Interactive charts & full statements → Open the IDXX valuation workbench →

IDXX Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$4.6B	$4.3B	$3.9B	$3.7B	$3.4B	$3.2B	$2.7B	$2.4B	$2.2B	$2.0B	$1.8B	$1.6B	$1.5B	$1.4B	$1.3B	$1.2B	$1.1B	$1.0B	$1.0B	$923M	$739M
Gross Profit	$2.8B	$2.7B	$2.4B	$2.2B	$2.0B	$1.9B	$1.6B	$1.4B	$1.2B	$1.1B	$975M	$890M	$816M	$756M	$699M	$647M	$579M	$526M	$530M	$464M	$380M
Gross Margin %	62.5%	61.8%	61.0%	59.8%	59.5%	58.8%	58.0%	56.7%	56.1%	55.7%	54.9%	55.6%	54.9%	54.9%	54.1%	53.0%	52.4%	51.0%	51.7%	50.2%	51.3%
Operating Income (EBIT)	$1.5B	$1.4B	$1.1B	$1.1B	$899M	$932M	$695M	$553M	$491M	$413M	$350M	$300M	$260M	$267M	$263M	$236M	$204M	$176M	$172M	$136M	$128M
Operating Margin %	32.0%	31.6%	28.9%	30.0%	26.7%	29.0%	25.7%	23.0%	22.2%	21.0%	19.7%	18.7%	17.5%	19.4%	20.3%	19.4%	18.5%	17.1%	16.8%	14.8%	17.3%
Net Income	$1.1B	$1.1B	$888M	$845M	$679M	$745M	$582M	$428M	$377M	$263M	$222M	$192M	$182M	$188M	$178M	$162M	$141M	$122M	$116M	$94M	$94M
Net Margin %	25.0%	24.6%	22.8%	23.1%	20.2%	23.2%	21.5%	17.8%	17.0%	13.4%	12.5%	12.0%	12.2%	13.6%	13.8%	13.3%	12.8%	11.8%	11.3%	10.2%	12.7%
EBITDA	$1.6B	$1.5B	$1.3B	$1.1B	$1.0B	$1.0B	$791M	$641M	$575M	$496M	$428M	$370M	$319M	$321M	$315M	$284M	$250M	$226M	$221M	$177M	$158M
Earnings Per Share (EPS)	$14.13	$13.13	$10.69	$10.06	$8.03	$8.60	$6.71	$4.89	$4.26	$2.94	$2.44	$2.05	$1.79	$1.74	$1.59	$1.39	$1.19	$1.01	$0.93	$0.73	$0.71
Shares Outstanding (M)	81M	81M	83M	84M	85M	87M	87M	88M	88M	90M	91M	94M	102M	108M	112M	116M	119M	121M	124M	129M	132M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDXX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$1.2B	$1.1B	$1.1B	$1.1B	$1.1B	$998M	$954M	$976M
Gross Profit	$779M	$723M	$658M	$683M	$695M	$623M	$571M	$596M
Gross Margin %	64.0%	63.3%	60.4%	61.8%	62.6%	62.4%	59.8%	61.1%
Operating Income (EBIT)	$426M	$363M	$316M	$355M	$373M	$317M	$262M	$304M
Operating Margin %	35.0%	31.8%	28.9%	32.1%	33.6%	31.7%	27.4%	31.1%
Net Income	$338M	$278M	$248M	$275M	$294M	$243M	$216M	$233M
Net Margin %	27.8%	24.4%	22.8%	24.9%	26.5%	24.3%	22.7%	23.9%
EBITDA	$468M	$401M	$356M	$392M	$409M	$352M	$299M	$342M
Earnings Per Share (EPS)	$4.19	$3.45	$3.08	$3.40	$3.63	$2.96	$2.60	$2.80
Shares Outstanding (M)	81M	81M	81M	81M	81M	82M	83M	83M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDXX Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.4B	$1.2B	$929M	$907M	$543M	$756M	$648M	$459M	$400M	$373M	$335M	$216M	$236M	$246M	$230M	$221M	$179M	$174M	$143M	$135M	$110M
Capital Expenditures (CapEx)	$117M	$125M	$131M	$134M	$149M	$120M	$108M	$155M	$123M	$77M	$65M	$83M	$61M	$79M	$69M	$100M	$39M	$58M	$90M	$66M	$71M
Free Cash Flow (FCF)	$1.3B	$1.1B	$798M	$773M	$394M	$636M	$540M	$304M	$277M	$297M	$270M	$133M	$175M	$167M	$161M	$120M	$140M	$116M	$53M	$69M	$38M
FCF Margin %	27.5%	24.5%	20.5%	21.1%	11.7%	19.8%	20.0%	12.6%	12.5%	15.1%	15.2%	8.3%	11.8%	12.2%	12.5%	9.9%	12.7%	11.2%	5.2%	7.5%	5.2%
Dividends Paid	—	—	—	—	—	$47M	$51M	$36M	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDXX Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$347M	$266M	$352M	$402M	$186M	$238M	$262M	$220M
Capital Expenditures (CapEx)	$25M	$32M	$29M	$31M	$34M	$30M	$39M	$28M
Free Cash Flow (FCF)	$323M	$234M	$323M	$371M	$152M	$208M	$223M	$192M
FCF Margin %	26.5%	20.5%	29.6%	33.6%	13.7%	20.8%	23.3%	19.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDXX Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$3.4B	$3.4B	$3.3B	$3.3B	$2.7B	$2.4B	$2.3B	$1.8B	$1.5B	$1.7B	$1.5B	$1.5B	$1.4B	$1.2B	$1.1B	$1.0B	$897M	$809M	$765M	$702M	$560M
Cash & Cash Equivalents	$197M	$180M	$288M	$454M	$113M	$144M	$384M	$90M	$124M	$188M	$155M	$129M	$323M	$279M	$224M	$184M	$157M	$107M	$79M	$60M	$62M
Total Liabilities	$1.8B	$1.7B	$1.7B	$1.8B	$2.1B	$1.7B	$1.7B	$1.7B	$1.5B	$1.8B	$1.6B	$1.6B	$1.3B	$712M	$467M	$491M	$323M	$294M	$327M	$264M	$150M
Total Debt (Short + Long-Term)	$996M	$875M	$618M	$968M	$1.4B	$944M	$926M	$1.0B	$1.0B	$1.3B	$1.2B	$1.2B	$899M	$428M	$215M	$246M	$133M	$124M	$156M	$79M	$7M
Total Shareholders' Equity	$1.6B	$1.6B	$1.6B	$1.5B	$609M	$690M	$632M	$177M	($10M)	($54M)	($108M)	($84M)	$118M	$518M	$636M	$540M	$574M	$515M	$438M	$438M	$410M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IDXX viewer.

IDXX Metric Deep Dives

Other Companies in Health Care Equipment

SYK · Stryker Corporation — $106 billion
BSX · Boston Scientific — $63 billion
EW · Edwards Lifesciences — $51 billion
BDX · Becton Dickinson — $49 billion
DXCM · Dexcom — $34 billion
RMD · ResMed — $32 billion
GEHC · GE HealthCare — $29 billion
STE · Steris — $20 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← IDX All “I” companies IDYA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.